-
EP2240164
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2240164
| EP2240164 - PHARMACEUTICAL COMPOSITION [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 28.10.2016 Database last updated on 20.07.2024 | Most recent event Tooltip | 28.10.2016 | Application deemed to be withdrawn | published on 30.11.2016 [2016/48] | Applicant(s) | For all designated states Novartis AG Lichtstrasse 35 4056 Basel / CH | [2010/42] | Inventor(s) | 01 /
KOCHHAR, Charu Falkensteinerstrasse 40 CH-4053 Basel / CH | 02 /
DEODHAR, Unmesh Oberwilerstrasse 16 CH-4102 Binningen / CH | 03 /
KERUDI, Aravind Unichem Laboratories 16 Plot Nos 17&18 Pilerne Industrial Estate Pilerne Bardez GOA-403511 / IN | 04 /
BABU, G.V. M. Unichem Laboratories 16 Plot Nos 17&18 Pilerne Industrial Estate Pilerne Bardez GOA-403511 / IN | [2010/42] | Representative(s) | Roth, Peter Richard Novartis Pharma AG Patent Department 4002 Basel / CH | [N/P] |
| Former [2010/42] | Roth, Peter Richard Novartis Pharma AG Patent Department 4002 Basel / CH | Application number, filing date | 08865096.5 | 19.12.2008 | [2010/42] | WO2008EP68051 | Priority number, date | EP20070150347 | 21.12.2007 Original published format: EP 07150347 | [2010/42] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2009080762 | Date: | 02.07.2009 | Language: | EN | [2009/27] | Type: | A2 Application without search report | No.: | EP2240164 | Date: | 20.10.2010 | Language: | EN | The application published by WIPO in one of the EPO official languages on 02.07.2009 takes the place of the publication of the European patent application. | [2010/42] | Search report(s) | International search report - published on: | EP | 11.09.2009 | Classification | IPC: | A61K9/20, A61K31/404 | [2010/42] | CPC: |
A61K9/2018 (EP,US);
A61K31/404 (EP,US);
A61P1/04 (EP);
A61P1/16 (EP);
A61P11/00 (EP);
A61P11/06 (EP);
A61P11/16 (EP);
A61P13/12 (EP);
A61P17/04 (EP);
A61P17/06 (EP);
A61P17/08 (EP);
A61P19/02 (EP);
A61P21/02 (EP);
A61P21/04 (EP);
A61P25/00 (EP);
A61P25/28 (EP);
A61P27/02 (EP);
A61P29/00 (EP);
A61P3/10 (EP);
A61P31/00 (EP);
A61P31/04 (EP);
A61P31/18 (EP);
A61P35/00 (EP);
A61P37/00 (EP);
A61P37/02 (EP);
A61P37/06 (EP);
A61P37/08 (EP);
A61P5/14 (EP);
A61P9/00 (EP);
A61P9/04 (EP);
A61P9/10 (EP);
A61P9/12 (EP);
A61P9/14 (EP);
A61K9/2077 (EP,US)
(-)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR [2010/42] | Title | German: | PHARMAZEUTISCHE ZUSAMMENSETZUNG | [2010/42] | English: | PHARMACEUTICAL COMPOSITION | [2010/42] | French: | COMPOSÉS ORGANIQUES | [2010/42] | Entry into regional phase | 21.07.2010 | National basic fee paid | 21.07.2010 | Designation fee(s) paid | 21.07.2010 | Examination fee paid | Examination procedure | deleted | Communication of intention to grant the patent | 20.05.2010 | Amendment by applicant (claims and/or description) | 21.07.2010 | Examination requested [2010/42] | 01.07.2016 | Application deemed to be withdrawn, date of legal effect [2016/48] | 27.07.2016 | Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2016/48] | Fees paid | Renewal fee | 15.12.2010 | Renewal fee patent year 03 | 12.12.2011 | Renewal fee patent year 04 | 11.12.2012 | Renewal fee patent year 05 | 12.12.2013 | Renewal fee patent year 06 | 11.12.2014 | Renewal fee patent year 07 | Penalty fee | Additional fee for renewal fee | 31.12.2015 | 08 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]WO03082859 (NOVARTIS AG [CH], et al) [A] 1-11 * the whole document *; | [XD]WO2006092255 (NOVARTIS AG [CH], et al) [XD] 1-11 * page 9 - page 10; claims 1,9,18,20,21,25,28 *; | [A] - DAVIS P D ET AL, "INHIBITORS OF PROTEIN KINASE C 1. 2,3-BISARYLMALEIMIDES", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY. WASHINGTON, (19920101), vol. 35, no. 1, ISSN 0022-2623, pages 177 - 184, XP000910195 [A] 1-11 * the whole document * DOI: http://dx.doi.org/10.1021/jm00079a024 |